Clinical Trial 45955

Long Beach, CA 90806


The purpose of this study is to evaluate the long-term safety of BHV-3500 (Zavegepant) intranasal in the acute treatment of migraine.

  • 2-8 moderate to severe migraines/month within the last 3 months
  • Migraine attacks present for more than 1 year with age of onset of migraines prior to 50 years of age
  • Migraine attacks, on average, lasting about 4-72 hours if untreated
  • Less than 15 days with headaches (migraine or non-migraine) per month in each of the 3 months prior to the screening visit
  • Ability to distinguish migraine attacks from tension/cluster headaches
  • Subjects with contraindications for use of triptans may be included provided they meet all other study entry criteria

Qualified Participants May Receive:

Compensation up to $1,100 over the study length (90 days).

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.